​FDA approves Cambridge-based Vericel's knee cartilage repair product

Shares of Cambridge-based Vericel surged late Tuesday after the FDA approved a treatment for knee cartilage repair that involves harvesting a patient ’s own cells. The FDA said it had approved Vericel's Maci, a product that collects and expands a patient’s cells — called autologous cells — then places them onto a collagen membrane that is implanted over the area where tissue was removed. Vericel has two other FDA-approved products, skin graft treatment Epicel and another knee cartilage repair…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news